Skip to main content
. 2018 Jan 17;8:932. doi: 10.1038/s41598-018-19610-9

Figure 2.

Figure 2

S-Thiolation of HSA from hyperlipidemia patients. (A) Non-reducing SDS-PAGE (left panel) and native-PAGE (right panel) analysis of peak 1 and peak 2 HSA. (B) Linear mode MALDI-TOF/TOF MS spectrum of peak 1 and peak 2 HSA. (C) Anion-exchange liquid chromatography of DTT treated peak 1 and peak 2 HSA. Purified peak 1 and peak 2 HSA were treated with or without DTT for 3 h.